Exagen Inc (XGN)
1.40
+0.02
(+1.08%)
USD |
NASDAQ |
May 03, 16:00
1.41
+0.01
(+0.71%)
After-Hours: 20:00
Exagen Debt to Equity Ratio: 0.859 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.859 |
| September 30, 2023 | 0.7073 |
| June 30, 2023 | 0.6084 |
| March 31, 2023 | 0.8166 |
| December 31, 2022 | 0.6822 |
| September 30, 2022 | 0.4985 |
| June 30, 2022 | 0.4336 |
| March 31, 2022 | 0.3631 |
| December 31, 2021 | 0.3235 |
| September 30, 2021 | 0.3005 |
| June 30, 2021 | 0.2809 |
| March 31, 2021 | 0.2647 |
| December 31, 2020 | 0.6372 |
| September 30, 2020 | 0.5948 |
| June 30, 2020 | 0.5487 |
| March 31, 2020 | 0.5155 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.4645 |
| September 30, 2019 | 0.4378 |
| June 30, 2019 | -35.78 |
| March 31, 2019 | |
| December 31, 2018 | -3.656 |
| September 30, 2018 | |
| December 31, 2015 | -1.166 |
| September 30, 2015 | -1.150 |
| June 30, 2015 | -1.186 |
| March 31, 2015 | -1.174 |
| December 31, 2014 | -1.309 |
| September 30, 2014 | -1.552 |
| June 30, 2014 | -2.012 |
| March 31, 2014 | |
| December 31, 2013 | 19.54 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-35.78
Minimum
Jun 2019
0.859
Maximum
Dec 2023
-1.392
Average
0.4985
Median
Sep 2022
Debt to Equity Ratio Benchmarks
| Fonar Corp | 0.0008 |
| XWELL Inc | 0.00 |
| ProPhase Labs Inc | 0.2077 |
| Applied DNA Sciences Inc | 0.00 |
| Veracyte Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 56.94M |
| Total Liabilities (Quarterly) | 34.25M |
| Shareholders Equity (Quarterly) | 22.69M |
| Current Ratio | 4.020 |
| Net Debt Paydown Yield | 5.02% |